• Portrait of Michael Jackson
  • Associate professor

    Max Rady College of Medicine
    Pharmacology and Therapeutics
    A205-753 McDermot Avenue
    University of Manitoba
    Winnipeg, Manitoba R3E 0T6

    Phone: 204-789-3951

Accepting graduate students

Research affiliations

Research summary

Dr. Michael Jackson’s research seeks to understand how families of Ca2+-permeable channels, contribute to Ca2+ dysregulation, aberrant inflammation, impaired synaptic transmission and plasticity underlying cognitive decline in models of stroke and Alzheimer’s disease. This focus follows from a body of work demonstrating that Ca2+ permeable channels, including the transient receptor potential melastatin type 2 (TRPM2) and pannexin, are functionally coupled to the NMDA glutamate receptor subtype and contribute to physiological and pathological processes initiated as a consequence of activating theses receptors. A primary aim is to gain mechanistic insight into how these Ca2+ influx pathways are regulated by intracellular signalling pathways, with a goal of identifying molecular targets for development of agents effective in treating neurodegenerative disorders.


Dr. Michael Jackson is an associate professor in pharmacology and therapeutics at the University of Manitoba. His laboratory is located in the neurosciences research laboratories in the Kleysen Institute for Advanced Medicine (KIAM). Dr. Jackson obtained his PhD in pharmacology from McGill University. Following postdoctoral training in physiology at the University of Toronto, he moved to the Robarts Research Institute at Western University in 2008 as a research scientist and adjunct professor of physiology and pharmacology.


ORCID profile

Visit Michael Jackson's ORCID profile for a complete listing.

Michael Jackson's profile

Contact us

Postgraduate Medical Education (PGME)
Max Rady College of Medicine
260 Brodie Centre, 727 McDermot Avenue
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 3P5 Canada